Thursday, March 28, 2024
News

New cheap, DNA vaccine may offer protection from coronavirus

   SocialTwist Tell-a-Friend    Print this Page   COMMENT

New York | Tuesday, 2021 10:15:06 PM IST
US researchers have developed a novel, low-cost DNA-based vaccine that may not only provide protection against existing variants of coronavirus, but also against its future strains.

The vaccine, which will cost about $1 a dose, has shown promising results in early animal testing, said the team from University of Virginia and Virginia Polytechnic Institute and State University.

"Our new platform offers a new route to rapidly produce vaccines at very low cost that can be manufactured in existing facilities around the world, which should be particularly helpful for pandemic response," said Steven L. Zeichner from the UVA Health. The study is detailed in the journal PNAS.

Zeichner's new vaccine-production platform involves synthesizing DNA that directs the production of a piece of the virus that can instruct the immune system how to mount a protective immune response against the virus.

That DNA is inserted into another small circle of DNA called a plasmid that can reproduce within bacteria. The plasmid is then introduced into bacteria, instructing the bacteria to place pieces of proteins on their surfaces. The technique uses the common bacteria E. coli.

To produce the vaccine, the bacteria expressing the vaccine antigen are simply grown in a fermenter, much like the fermenters used in common microbial industrial processes like brewing, and then killed with a low concentration of formalin.

"Killed whole-cell vaccines are currently in widespread use to protect against deadly diseases like cholera and pertussis. Factories in many low-to-middle-income countries around the world are making hundreds of millions of doses of those vaccines per year now, for a $1 per dose or less," Zeichner said.

"It may be possible to adapt those factories to make this new vaccine. Since the technology is very similar, the cost should be similar too."

The entire process, from identifying a potential vaccine target to producing the gene-deleted bacteria that have the vaccine antigens on their surfaces, can take place very quickly, in only two to three weeks, making the platform ideal for responding to a pandemic, the researchers said.

--IANS rvt/dpb

( 352 Words)

2021-04-20-16:02:03 (IANS)

 
  LATEST COMMENTS (0)
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
 
MORE SCIENCE NEWS
AI technique accurately predicts deadly ...
Researchers discover new approach to tre...
Researchers discover how gene mutation r...
Climate change disrupts vital ecosystems...
Study finds how ageing reduces ability o...
Israeli researchers uncover biological p...
More...
 
INDIA WORLD ASIA
'INDIA bloc has no presence; united to a...
'For elections, people support needed, n...
AAP workers protesting against Kejriwal'...
'Will fight till the end': Congress lead...
India Coast Guard evacuates ailing man f...
UP's improved law and order to be the do...
More...    
 
 Top Stories
In close touch with Indians on boar... 
Pakistan's top court allows militar... 
"BJP candidates will win with a rec... 
"Gave suggestions to State Election... 
Babbar Khalsa International terror ... 
Chengicherla violence: BJP MLA clai... 
Abu Dhabi Chamber establishes worki... 
IPL 2024: Riyan Parag's batting fir...